Cost-Effectiveness of Dapagliflozin as Add-On to Insulin for the Treatment of Type 2 Diabetes in the Netherlands

Nov 1, 2013, 00:00
10.1016/j.jval.2013.08.678
https://www.valueinhealthjournal.com/article/S1098-3015(13)02583-7/fulltext
Title : Cost-Effectiveness of Dapagliflozin as Add-On to Insulin for the Treatment of Type 2 Diabetes in the Netherlands
Citation : https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(13)02583-7&doi=10.1016/j.jval.2013.08.678
First page : A441
Section Title : Disease-Specific Studies
Open access? : No
Section Order : 653
Categories :
Tags :
Regions :
ViH Article Tags :